PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2018

Jan 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2018-01-22

Reporting Person: BRYCE RICHARD PAUL (SR VP, CLINICAL RESEARCH & DEV)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-22	COMMON STOCK	S	1860	$92.75	Disposed	25379	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.